1,502 Shares in Waters Corporation $WAT Acquired by Brookstone Capital Management

Brookstone Capital Management acquired a new stake in Waters Corporation (NYSE:WAT) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 1,502 shares of the medical instruments supplier’s stock, valued at approximately $447,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in WAT. Fundsmith LLP boosted its stake in Waters by 9.6% during the 3rd quarter. Fundsmith LLP now owns 3,955,498 shares of the medical instruments supplier’s stock worth $1,185,898,000 after purchasing an additional 347,091 shares during the last quarter. Geode Capital Management LLC lifted its stake in shares of Waters by 0.5% in the fourth quarter. Geode Capital Management LLC now owns 1,593,388 shares of the medical instruments supplier’s stock worth $602,921,000 after buying an additional 8,590 shares in the last quarter. Invesco Ltd. boosted its position in Waters by 32.3% during the third quarter. Invesco Ltd. now owns 1,472,419 shares of the medical instruments supplier’s stock worth $441,446,000 after acquiring an additional 359,596 shares during the last quarter. Fundsmith Investment Services LTD. boosted its position in Waters by 11.1% during the third quarter. Fundsmith Investment Services LTD. now owns 1,356,289 shares of the medical instruments supplier’s stock worth $406,629,000 after acquiring an additional 135,504 shares during the last quarter. Finally, Veritas Asset Management LLP grew its stake in Waters by 112.3% during the 4th quarter. Veritas Asset Management LLP now owns 1,241,206 shares of the medical instruments supplier’s stock valued at $471,447,000 after acquiring an additional 656,436 shares in the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Waters in a report on Monday, April 20th. Evercore upgraded Waters from an “in-line” rating to an “outperform” rating and set a $350.00 price target for the company in a research report on Monday, April 6th. The Goldman Sachs Group raised Waters to a “strong-buy” rating in a report on Wednesday, April 1st. Sanford C. Bernstein began coverage on Waters in a research report on Friday. They set an “outperform” rating and a $435.00 price objective on the stock. Finally, Wells Fargo & Company boosted their price objective on Waters from $355.00 to $370.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 14th. Three research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $396.68.

Waters Stock Up 0.1%

Shares of NYSE WAT opened at $374.97 on Monday. The company has a 50 day simple moving average of $346.96 and a 200-day simple moving average of $347.21. The company has a market capitalization of $36.82 billion, a P/E ratio of 47.65, a P/E/G ratio of 2.26 and a beta of 1.21. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.79 and a quick ratio of 1.13. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $414.15.

Waters (NYSE:WAT) last released its quarterly earnings data on Tuesday, May 5th. The medical instruments supplier reported $2.70 EPS for the quarter, beating analysts’ consensus estimates of $2.31 by $0.39. The firm had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.20 billion. Waters had a return on equity of 15.60% and a net margin of 11.91%.The firm’s quarterly revenue was up 91.4% on a year-over-year basis. During the same period in the prior year, the firm posted $2.25 earnings per share. Waters has set its Q2 2026 guidance at 2.950-3.050 EPS and its FY 2026 guidance at 14.400-14.600 EPS. On average, equities research analysts predict that Waters Corporation will post 14.51 earnings per share for the current year.

About Waters

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.